Superior Planning, LLC’s Amgen AMGN Stock Holding History

Superior Planning, LLC’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$80.1K	Buy	+190	New	+$75.7K	0.03%	270

Other funds holding AMGN

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Superior Planning, LLC's AMGN Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Amgen (AMGN) in Q3 2026: 190 shares worth $80.1K. The stake represents 0.03% of the portfolio and ranks #270 among its holdings.

2,550 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Superior Planning, LLC held 190 shares of Amgen worth $80.1K as of Q3 2026.
Amgen was a new Superior Planning, LLC position in Q3 2026.
Amgen made up 0.03% of Superior Planning, LLC's portfolio in Q3 2026, its #270 holding.
2,550 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.